¼¼°èÀÇ ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀå : ±âȸ¿Í Àü·«(-2032³â)
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032
»óǰÄÚµå : 1385980
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2023³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 421 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 6,883,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,325,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,767,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÌ º¸°í¼­´Â Àü·«°¡, ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× °íÀ§ °æ¿µÁøÀÌ COVID-19 »çÅ ÀÌÈÄ ¼¼°è ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀåÀ» Æò°¡ÇÏ´Â µ¥ ÇÊ¿äÇÑ ÇÙ½É Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO)ÀÇ °¡Àå Å©°í ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀº ¾îµðÀϱî? ÀÌ ½ÃÀåÀº Àüü °æÁ¦, Àα¸ Åë°è ¹× ±âŸ À¯»ç ½ÃÀå°ú ¾î¶»°Ô ¿¬°üµÇ¾î Àִ°¡? ¾ÕÀ¸·Î ¾î¶² ÈûÀÌ ½ÃÀåÀ» Çü¼ºÇÒ °ÍÀΰ¡? ÀÌ º¸°í¼­´Â ÀÌ ¸ðµç Áú¹®°ú ´õ ¸¹Àº Áú¹®¿¡ ´ëÇÑ ÇØ´äÀ» Á¦½ÃÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ½ÃÀå Æ¯¼º, ±Ô¸ð¿Í ¼ºÀå, ¼¼ºÐÈ­, Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®, °æÀï »óȲ, ½ÃÀå Á¡À¯À², ½ÃÀå µ¿Çâ ¹× Àü·«¿¡ ´ëÇØ Á¶»çÇß½À´Ï´Ù. Áö¿ªº° ½ÃÀåÀÇ °ú°Å ¹× ¿¹Ãø ¼ºÀå·üÀ» Á¶»çÇÕ´Ï´Ù. ¶ÇÇÑ, Àüü ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀå ³»¿¡¼­ÀÇ À§Ä¡¸¦ ÆÄ¾ÇÇÏ¿© ´Ù¸¥ ½ÃÀå°úÀÇ ºñ±³µµ ÇÔ²² ´Ù·ç°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå ±×¸²¸ñÂ÷

Á¦4Àå Ç¥¸ñÂ÷

Á¦5Àå º¸°í¼­ ±¸Á¶

Á¦6Àå ¼­·Ð°ú ½ÃÀå Æ¯Â¡

Á¦7Àå ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦8Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦9Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦10Àå ¼¼°èÀÇ ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀå ¼¼ºÐÈ­

Á¦11Àå ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀå, Áö¿ª ¹× ±¹°¡ ºÐ¼®

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦13Àå ¼­À¯·´ ½ÃÀå

Á¦14Àå µ¿À¯·´ ½ÃÀå

Á¦15Àå ºÏ¹Ì ½ÃÀå

Á¦16Àå ³²¹Ì ½ÃÀå

Á¦17Àå Áßµ¿ ½ÃÀå

Á¦18Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦19Àå °æÀï »óȲ°ú ±â¾÷ °³¿ä

Á¦20Àå ÁÖ¿ä ÀμöÇÕº´

Á¦21Àå ±âȸ¿Í Àü·«

Á¦22Àå ÀǾàǰ °³¹ßÁ¦Á¶¼öʱâ°ü(CDMO) ½ÃÀå, °á·Ð°ú Á¦¾È

Á¦23Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

“Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical contract development and manufacturing organization (CDMO) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (CDMO)? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? “The pharmaceutical contract development and manufacturing organization (CDMO) market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical contract development and manufacturing organization (CDMO) market; and compares it with other markets.

The report covers the following chapters:

Introduction And Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the pharmaceutical contract development and manufacturing organization (CDMO) market.

Key Trends

Highlights the major trends shaping the global pharmaceutical contract development and manufacturing organization (CDMO) market. This section also highlights likely future developments in the market.

Macro-Economic Scenario

The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on the global and regional markets, providing strategic insights for businesses in the pharmaceutical contract development and manufacturing organization (CDMO) market.

Global Market Size And Growth

Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis

Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.

Market Segmentation

Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by type, by CMO service, by CRO service and by end user in the market.

Regional Market Size And Growth

Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section Includes recommendations for pharmaceutical contract development and manufacturing organization (CDMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction And Market Characteristics

7. Pharmaceutical Contract Development And Manufacturing Organization Market - Macro-Economic Scenario

8. Major Market Trends

9. Global Market Size and Growth

10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market Segmentation

11. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Regional and Country Analysis

12. Asia-Pacific Market

13. Western Europe Market

14. Eastern Europe Market

15. North America Market

16. South America Market

17. Middle East Market

18. Africa Market

19. Competitive Landscape and Company Profiles

20. Key Mergers And Acquisitions

21. Opportunities And Strategies

22. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations

23. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â